Analyst firms · Evercore ISI · ZBH

Evercore ISI ZBH price target and rating history

Zimmer Biomet Holdings Inc. (ZBH) · Health Care

Evercore ISI rates Zimmer Biomet Holdings Inc. (ZBH) Outperform with a $210 price target, as of its latest action on Jan 5, 2026. It has published 4 rating actions on ZBH since January 2023, including 2 upgrades and 2 downgrades. Across 6 firms with a ZBH price target in the last 12 months, the median target is $100. Evercore ISI's $210 is 110% above that.

Current rating

Outperform

Price target

$210

Median target, all firms

$100

Actions on ZBH

4

Evercore ISI price target on ZBH

Every Evercore ISI rating on ZBH

• Jan 5, 2026
  UpgradeEvercore ISI upgrades to Outperform from In-line, price target $210
• Jan 4, 2024
  DowngradeEvercore ISI downgrades to In-line from Outperform, price target $135 to $125
• Apr 11, 2023
  UpgradeEvercore ISI upgrades to Outperform from In-line, price target $135 to $148
• Jan 3, 2023
  DowngradeEvercore ISI downgrades to In-line from Outperform, price target $130

How other firms rate ZBH

Each firm's latest rating and stated target in the last 12 months.

Questions about Evercore ISI and ZBH

What is Evercore ISI's price target for ZBH?

Evercore ISI's latest stated price target for Zimmer Biomet Holdings Inc. (ZBH) is $210, from its action on Jan 5, 2026.

What is Evercore ISI's rating on ZBH?

Evercore ISI rates ZBH Outperform, a bullish rating, as of Jan 5, 2026.

When did Evercore ISI last change its view on ZBH?

On Jan 5, 2026, Evercore ISI upgrades to Outperform from In-line, price target $210.

How does Evercore ISI's ZBH target compare with other analysts?

Across 6 firms with a ZBH price target in the last 12 months, the median target is $100. Evercore ISI's $210 is 110% above that.

More ZBH rating histories

• Barclays3
• UBS4
• BTIG3
• Raymond James3
• Piper Sandler3
• Jefferies3
• RBC Capital Markets3
• Wells Fargo3
• Needham4
• Truist Securities3
• Loop Capital3

All Evercore ISI ratingsZBH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.